positions available now

Category Archives: Market Access

Relating to Market Access sector of Life Sciences Industry

Commercial Eyes Recruiting: Market Access Professional

Commercial Eyes has a great opportunity for a Market Access Professional to join our established Market Access team in the capacity of Senior Consultant or Consultant. These roles are pivotal to enhancing our comprehensive and competitive pricing and reimbursement practice … Continue reading

Posted in Commercial Eyes, Market Access, Recruiting | Tagged , , | Comments Off on Commercial Eyes Recruiting: Market Access Professional

Commercial Eyes Recruiting: Senior Market Access Consultant

Commercial Eyes has a great opportunity for a Senior Market Access consultant to join our dynamic Market Access team. Reporting to the Health Economics and Market Access Manager, this senior consulting role offers the successful candidate the opportunity to gain … Continue reading

Posted in Commercial Eyes, Life Sciences Industry, Market Access | Tagged , , | Comments Off on Commercial Eyes Recruiting: Senior Market Access Consultant

Ready? Get Set…Go! Planning the most appropriate strategy for your product to enter the Australian market

As we weave our way through life, we plan…plan our career, plan our finances, plan a holiday and most of us would have at least once in our lifetime planned a party. The key to a successful plan is finding … Continue reading

Posted in Life Sciences Industry, Market Access, PBAC, Regulatory Services, TGA | Tagged , | Comments Off on Ready? Get Set…Go! Planning the most appropriate strategy for your product to enter the Australian market

Multi-criteria decision making – How can non-health attributes be considered and valued?

Pressure is mounting on decisions to recommend and continue funding health technologies. Concerns around the rising cost of new medicines, an ageing population with greater resource utilisation, federal and state healthcare budgetary constraints, and an increasing dependency ratio (the ratio … Continue reading

Posted in Life Sciences Industry, Market Access, PBAC | Tagged | Comments Off on Multi-criteria decision making – How can non-health attributes be considered and valued?

Contemporary Economic Modelling – State of the Art

The Albert Einstein adage, “Everything should be made as simple as possible, but not simpler.” was the overarching principal that economic modellers should adhere to, communicated in the quarterly workshop session “Contemporary Economic Modelling”, attended by members of Commercial Eyes’ … Continue reading

Posted in Commercial Eyes, Life Sciences Industry, Market Access | Tagged , , | Comments Off on Contemporary Economic Modelling – State of the Art

Commercial Eyes Recruiting: Market Insight Manager

Commercial Eyes has an exciting opportunity for a Market Insight Manager Due to the growth and structural change in the Commercial Eyes business over the last three years, we are hiring a Market Insight Manager on a full time basis, … Continue reading

Posted in Commercial Eyes, Market Access | Tagged , , | Comments Off on Commercial Eyes Recruiting: Market Insight Manager

The PBAC major submission deadline is nearly here. Are you prepared for lodgement?

With the March 2016 major submission deadline looming, a significant but commonly overlooked aspect are the key administrative documents that accompany a lodged submission.  With a number of key documents changing, either in new process or content, as well as … Continue reading

Posted in E-Health/Technology, Market Access, PBAC | Tagged , | Comments Off on The PBAC major submission deadline is nearly here. Are you prepared for lodgement?

Innovation in Healthcare: Aligning clinical development and commercial strategies

Innovation is a crucial ingredient to providing breakthroughs in the life sciences sector. From penicillin to the human genome, innovation can generate great leaps in science. On November 30, BioMelbourne Network launched Victoria’s Innovation Week by celebrating the positive advances … Continue reading

Posted in BioMelbourne Network, Life Sciences Industry, Market Access | Tagged , , | Comments Off on Innovation in Healthcare: Aligning clinical development and commercial strategies

Pricing is important, but what about access and quality use of medicines?

The recent PBS Access and Sustainability package provides significant savings from pricing measures including removing the originator brand from price disclosure calculations, a one-off 5% reduction to F1 medicines listed for at least 5 years, flow on reductions for F2 … Continue reading

Posted in Life Sciences Industry, Market Access | Tagged , , | Comments Off on Pricing is important, but what about access and quality use of medicines?

Pricing uncertainty within the Pharmaceutical Benefits Scheme

Recent years have seen an active attempt to control Pharmaceutical Benefits Scheme (PBS) costs. Price disclosure and mandatory price cuts upon formulary transition have ensured prices of pharmaceuticals (especially generics) continue to tumble. Yet despite the use of these tools, … Continue reading

Posted in Life Sciences Industry, Market Access, PBAC, PBS | Tagged , | Comments Off on Pricing uncertainty within the Pharmaceutical Benefits Scheme
Copyright © 2014 Commercial Eyes